{"name": "MorphoSys",
 "permalink": "morphosys",
 "crunchbase_url": "http://www.crunchbase.com/company/morphosys",
 "homepage_url": "http://www.morphosys.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@morphosys.com",
 "phone_number": "49-(0)89-899-27-0",
 "description": "",
 "created_at": "Tue Oct 19 09:03:27 UTC 2010",
 "updated_at": "Tue Oct 19 09:08:54 UTC 2010",
 "overview": "\u003Cp\u003EMorphoSys AG, located in Martinsried/Munich, is one of the world\u0026#8217;s leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck \u0026amp; Co, Novartis, Pfizer, and Roche.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       57],
      "assets/images/resized/0010/6190/106190v1-max-150x150.jpg"],
     [[218,
       83],
      "assets/images/resized/0010/6190/106190v1-max-250x250.jpg"],
     [[218,
       83],
      "assets/images/resized/0010/6190/106190v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Karin",
      "last_name": "Eastham",
      "permalink": "karin-eastham",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0026/4129/264129v1-max-150x150.jpg"],
          [[128,
            176],
           "assets/images/resized/0026/4129/264129v1-max-250x250.jpg"],
          [[128,
            176],
           "assets/images/resized/0026/4129/264129v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020101007e6a8001up\u0026r=Rss\u0026s=DJFVW",
    "source_description": "MorphoSys Buys Sloning For $26.4M, Gains Synthetic Bio Technology",
    "acquired_year": 2010,
    "acquired_month": 10,
    "acquired_day": 8,
    "company":
     {"name": "Sloning BioTechnology",
      "permalink": "sloning-biotechnology",
      "image":
       {"available_sizes":
         [[[150,
            45],
           "assets/images/resized/0008/0493/80493v1-max-150x150.jpg"],
          [[250,
            76],
           "assets/images/resized/0008/0493/80493v1-max-250x250.jpg"],
          [[259,
            79],
           "assets/images/resized/0008/0493/80493v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "Lena-Christ-Strasse 48",
    "address2": "82152 Martinsried/Planegg",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        127],
       "assets/images/resized/0010/6191/106191v1-max-150x150.jpg"],
      [[250,
        213],
       "assets/images/resized/0010/6191/106191v1-max-250x250.jpg"],
      [[450,
        383],
       "assets/images/resized/0010/6191/106191v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}